Pfizer, Novo Nordisk and Metsera
Digest more
Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma ...
As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
Zacks Investment Research on MSN
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Metsera said it expects the Pfizer deal to close promptly after a stockholder meeting scheduled for this coming Thursday ...
Better still, if interest rates drop, as they're generally expected to over the coming year, the interest income you'll get ...
Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...
Pfizer raised its 2025 profit forecast for the second time this year, as ongoing cost cuts helped make up for slow sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback